JPH04210974A - Production of aminoketones - Google Patents
Production of aminoketonesInfo
- Publication number
- JPH04210974A JPH04210974A JP3036527A JP3652791A JPH04210974A JP H04210974 A JPH04210974 A JP H04210974A JP 3036527 A JP3036527 A JP 3036527A JP 3652791 A JP3652791 A JP 3652791A JP H04210974 A JPH04210974 A JP H04210974A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- lower alkyl
- formula
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract description 16
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 62
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 23
- 150000002576 ketones Chemical class 0.000 claims abstract description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 15
- 150000001412 amines Chemical class 0.000 claims abstract description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 8
- 150000003222 pyridines Chemical class 0.000 claims abstract description 8
- 125000002541 furyl group Chemical group 0.000 claims abstract description 6
- 125000005843 halogen group Chemical group 0.000 claims abstract description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 4
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 4
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 18
- 150000001298 alcohols Chemical class 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 9
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims description 8
- DCEHUBFNABRDKB-UHFFFAOYSA-N 1-(3-phenyl-1,2-oxazol-5-yl)butan-1-one Chemical compound O1C(C(=O)CCC)=CC(C=2C=CC=CC=2)=N1 DCEHUBFNABRDKB-UHFFFAOYSA-N 0.000 claims description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 5
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 5
- 239000008098 formaldehyde solution Substances 0.000 claims description 5
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 5
- 125000001544 thienyl group Chemical group 0.000 claims description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 3
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical group CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 24
- 239000007864 aqueous solution Substances 0.000 abstract description 11
- 229910052736 halogen Inorganic materials 0.000 abstract description 5
- 239000003158 myorelaxant agent Substances 0.000 abstract description 5
- YOFLXLIHPZPCFM-UHFFFAOYSA-N 2-methyl-1-(3-phenyl-1,2-oxazol-5-yl)-3-piperidin-1-ylpropan-1-one Chemical compound C=1C(C=2C=CC=CC=2)=NOC=1C(=O)C(C)CN1CCCCC1 YOFLXLIHPZPCFM-UHFFFAOYSA-N 0.000 abstract description 2
- 150000003333 secondary alcohols Chemical class 0.000 abstract description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract 2
- 239000003513 alkali Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- 235000019441 ethanol Nutrition 0.000 description 27
- 239000000243 solution Substances 0.000 description 18
- 125000004432 carbon atom Chemical group C* 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 101150041968 CDC13 gene Proteins 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- -1 amine hydrochlorides Chemical class 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 150000002367 halogens Chemical group 0.000 description 4
- VTWKXBJHBHYJBI-SOFGYWHQSA-N (ne)-n-benzylidenehydroxylamine Chemical compound O\N=C\C1=CC=CC=C1 VTWKXBJHBHYJBI-SOFGYWHQSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- SFBZWEPXKJNXBY-UHFFFAOYSA-N 1-(3-phenyl-1,2-oxazol-5-yl)-2-(piperidin-1-ylmethyl)butan-1-one Chemical compound C=1C(C=2C=CC=CC=2)=NOC=1C(=O)C(CC)CN1CCCCC1 SFBZWEPXKJNXBY-UHFFFAOYSA-N 0.000 description 2
- GUASCDJSZHYNGR-UHFFFAOYSA-N 1-(3-phenyl-1,2-oxazol-5-yl)-2-(pyrrolidin-1-ylmethyl)butan-1-one Chemical compound C=1C(C=2C=CC=CC=2)=NOC=1C(=O)C(CC)CN1CCCC1 GUASCDJSZHYNGR-UHFFFAOYSA-N 0.000 description 2
- GJFHPYWSYQKGOE-UHFFFAOYSA-N 1-(3-phenyl-1,2-oxazol-5-yl)propan-1-one Chemical compound O1C(C(=O)CC)=CC(C=2C=CC=CC=2)=N1 GJFHPYWSYQKGOE-UHFFFAOYSA-N 0.000 description 2
- ZBRDJMFLJXFIGJ-UHFFFAOYSA-N 3-phenyl-1,2-oxazole Chemical compound O1C=CC(C=2C=CC=CC=2)=N1 ZBRDJMFLJXFIGJ-UHFFFAOYSA-N 0.000 description 2
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- LTFTWJYRQNTCHI-UHFFFAOYSA-N hex-1-yn-3-ol Chemical compound CCCC(O)C#C LTFTWJYRQNTCHI-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- UKSROXPBTOHYHR-UHFFFAOYSA-N 1-(3-phenyl-1,2-oxazol-5-yl)butan-1-ol Chemical compound O1C(C(O)CCC)=CC(C=2C=CC=CC=2)=N1 UKSROXPBTOHYHR-UHFFFAOYSA-N 0.000 description 1
- KHGDLLUKLAYAJN-UHFFFAOYSA-N 1-(3-phenyl-1,2-oxazol-5-yl)propan-1-ol Chemical compound O1C(C(O)CC)=CC(C=2C=CC=CC=2)=N1 KHGDLLUKLAYAJN-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- RGHPCLZJAFCTIK-UHFFFAOYSA-N 2-methylpyrrolidine Chemical compound CC1CCCN1 RGHPCLZJAFCTIK-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
[00011 [00011
【産業上の利用分野]本発明は、中枢性筋弛緩剤として
有用なアミノケトン類及びその中間体の製造法に関する
。
[0002]さらに詳しくは一般式[I]の化合物RC
HOH−CHRIR2を酸化して一般式[IV]の化合
物RCOCHRI R2を製造し、更にこの化合物から
一般式[VI]の化合物RCo CRI R2CH2
NR6R7を製造する方法に関する。
[0003]なお、R1R1、R2、R6、R7の意味
は後述する。
[0004]一般式[V I ]の化合物は新規化合物
であり、中枢性筋弛緩剤として有用である。
[0005]
【従来技術及びその問題点】二級アルコール類からケト
ン類の製造方法には、酸化剤として一般的にクロム酸等
の重金属類が知られている。
[0006]然しなから重金属類は生物学的またはその
他の点で有害であり、医薬品の製造法においてこれらを
使用することは好ましくない。
[0007]重金属類を用いない他の酸化剤を用いる方
法としては、例えば次亜塩素酸ナトリウムと相関移動触
媒の組み合わせを用いる方法(G、 A、 Lee等T
etrahedron Letters、 1641頁
、1976年)または、酢酸等の酸性溶媒の存在下、次
亜塩素酸カルシウムを用いる方法(S、 D、 Nwa
vkwa等Tetrahedron Letters、
35頁、1982年)が知られているが、これらの酸化
方法では一般式[I]のアルコール類より一般式[IV
]のケトン類は製造できなかった。
[0008]さらにケトン類よりアミノケトン類を製造
する方法としては、例えばケトン類をパラホルムアルデ
ヒドとアミン塩酸塩類をアルコール溶媒中、濃塩酸存在
下で反応する方法(特開昭63−119444号)が知
られているが、これによって製造されるアミノケトン類
はアミン部分が塩酸塩となるので適当なアルカリ剤、例
えばアンモニア水、水酸化ナトリウム水溶液等による中
和反応により遊離アミノケトン類とすることが必要であ
り、製造コストが高くなるとともに製造工程が煩雑にな
る等の不都合を避は得ない。
[0009][Industrial Field of Application] The present invention relates to a method for producing aminoketones and intermediates thereof useful as central muscle relaxants. [0002] More specifically, the compound RC of general formula [I]
HOH-CHRIR2 is oxidized to produce a compound RCOCHRI R2 of the general formula [IV], and from this compound a compound RCo CRI R2CH2 of the general formula [VI] is produced.
The present invention relates to a method of manufacturing NR6R7. [0003] The meanings of R1R1, R2, R6, and R7 will be described later. [0004] Compounds of general formula [V I ] are novel compounds and are useful as central muscle relaxants. [0005] [Prior Art and its Problems] Heavy metals such as chromic acid are generally known as oxidizing agents in the method for producing ketones from secondary alcohols. [0006] However, heavy metals are biologically or otherwise harmful, and their use in pharmaceutical manufacturing methods is undesirable. [0007] As a method using another oxidizing agent that does not use heavy metals, for example, a method using a combination of sodium hypochlorite and a phase transfer catalyst (G, A, Lee et al.
etrahedron Letters, p. 1641, 1976) or a method using calcium hypochlorite in the presence of an acidic solvent such as acetic acid (S, D, Nwa
Tetrahedron Letters such as vkwa,
35, 1982), but these oxidation methods produce alcohols of general formula [IV] rather than alcohols of general formula [I].
] Ketones could not be produced. [0008] Further, as a method for producing aminoketones from ketones, for example, a method is known in which ketones are reacted with paraformaldehyde and amine hydrochlorides in an alcohol solvent in the presence of concentrated hydrochloric acid (Japanese Patent Application Laid-Open No. 119444/1982). However, in the aminoketones produced by this method, the amine moiety becomes a hydrochloride, so it is necessary to generate free aminoketones through a neutralization reaction with an appropriate alkaline agent, such as aqueous ammonia or aqueous sodium hydroxide solution. However, inconveniences such as increased manufacturing costs and complicated manufacturing processes are unavoidable. [0009]
【課題を解決するための手段】本発明は、上述した問題
点を解決するためになされたものであり、中枢性筋弛緩
剤として優れた作用を有する化合物、即ち一般式[VI
]CO
R1
2
CH2
R6
7
[VI]
で表わされるアミノケトン類を製造するにあたり、式[
I]
RCHOHCHRI R2・・・[I]で表わされるア
ルコール類を一般式[II]M (0−X)
・・・[II]で表わされるハイポ
ハライド類および一般式[III][Means for Solving the Problems] The present invention has been made to solve the above-mentioned problems, and is directed to a compound having an excellent effect as a central muscle relaxant, that is, a compound of the general formula [VI
]CO R1 2 CH2 R6 7 [VI] In producing aminoketones represented by the formula [
I] RCHOHCHRI R2... Alcohols represented by [I] are represented by the general formula [II]M (0-X)
... Hypohalides represented by [II] and general formula [III]
【0010】0010
【化3】
一般
[III]
で表わされるピリジン類またはその酸付加塩の存在下反
応させ、一般式[IV]
R−Co−CHRI R2・・・[IV]で表わされる
ケトン類を製造し、さらに一般式[V]NHR6R7・
・・[V]
で表わされるアミン類とをホルムアルデヒド水溶液の存
在下で反応させることを特徴とするものである。
[00111即ち本発明の製造方法は下記反応式(1)
%式%(2)
][Chemical formula 3] A reaction is carried out in the presence of a pyridine represented by the general formula [III] or an acid addition salt thereof to produce a ketone represented by the general formula [IV] R-Co-CHRI R2...[IV], Furthermore, the general formula [V]NHR6R7・
... [V] It is characterized by reacting the amines represented by these in the presence of an aqueous formaldehyde solution. [00111 That is, the production method of the present invention is based on the following reaction formula (1)
% formula % (2) ]
【4】
M(0−X)、ll
および
[IIコ
またはその酸付加塩
[III]
ホルムアルデヒド
水溶液
で表わされる。 (各符号については以下に説明する。
)アルコール類
本発明の製造法において出発原料として用いられるアル
コール類は既に述べた通り、下記一般式[I]RCHO
HCHRI R2・・・[I]で表わされる。
[0013]一般式
%式%][4] M(0-X), ll and [II or acid addition salt thereof [III] Represented by an aqueous formaldehyde solution. (Each symbol will be explained below.) Alcohols As already stated, the alcohols used as starting materials in the production method of the present invention have the following general formula [I]RCHO
HCHRI R2...Represented by [I]. [0013] General formula % formula %]
【5】
[]
[0015]ただしR3はハロゲン;低級アルキル基;
ベンジル基;ベンゾイル基;ピリジル基;低級アルキル
基で置換されていても良いフリル基;低級アルキル基で
置換されていても良いチエニル基;ハロゲン、低級アル
コキシ基、低級アルキル基、トリフロロメチル基、シア
ノ基、ニトロ基、アミノ基、ジメチルアミノ基、アセト
アミド基、メタンスルホニルアミド基、アセチル基また
は低級アルコキシカルボニル基で置換されていても良い
フェニル基;またはナフチル基を表わす。また、R4及
びR5はそれぞれ独立してフェニル基または低級アルキ
ル基を、Wは酸素原子またはイオウ原子をそれぞれ表わ
す。
[0016] R+は水素原子;低級アルキル基;ベン
ジル基;メトキシ基;フェニル基;アリル基;トリフロ
ロメチル基もしくは低級アルコキシ基で置換した低級ア
ルキル基;またはシクロプロピルメチル基を表わす。
[0017] R2は水素原子または低級アルキル基を
それぞれ表わすか、またはR1とR2が連結して脂環式
五員環もしくは六員環を形成しているものであっても良
い。
[0018]なお、R4及びR5としての低級アルキル
基としては炭素数1または2のアルキル基が好ましく、
R3としての低級アルキル基としては炭素数1〜3のア
ルキル基が好ましく、R3としてのフリル基もしくはチ
エニル基に置換される低級アルキル基としては炭素数1
〜3のアルキル基が好ましく、R3としてのフェニル基
に置換される低級アルコキシ基、低級アルキル基及び低
級アルコキシカルボニル基のアルコキシ基としては炭素
数1または2のものが好ましい。
[0019]また、R1としての低級アルキル基として
は炭素数1〜4のアルキル基が好ましく、R1としての
低級アルコキシ基で置換した低級アルキル基としては、
炭素数1または2のアルコキシ基で置換した炭素数1ま
たは2の低級アルキル基が好ましい。
[00201また、R2としての低級アルキル基として
は炭素数1または2のアルキル基が好ましい。
ハイポハライド類
一方、上記一般式[I]のアルコール類と反応させるべ
きハイポハライド類は下記一般式[II]M (0−X
) ・・・[II]で表わ
される。
[00211一般式[II]において、Mはアルカリ金
属類またはアルカリ土類金属類を示す。アルカリ金属類
としては、たとえばリチウム、ナトリウム、カリウム、
セシウム等を挙げることができる。
[0022]アルカリ土類金属類としては、たとえばマ
グネシウム、カルシウム、ストロンチウム、バリウム等
を挙げることができる。
[0023]基Xはハロゲン原子を示し、たとえば塩素
、臭素、ヨウ素を挙げることができる。nはMがアルカ
リ金属類のときには1を、アルカリ土類金属類のときは
2を示す。
ピリジン類およびその酸付加塩
さらに上記一般式[I]のアルコール類を上記一般式[
II]のハイポハライド類と共に反応させるべきピリジ
ン類は下記一般式[III]
[0024][5] [] [0015] However, R3 is halogen; lower alkyl group;
Benzyl group; benzoyl group; pyridyl group; furyl group optionally substituted with lower alkyl group; thienyl group optionally substituted with lower alkyl group; halogen, lower alkoxy group, lower alkyl group, trifluoromethyl group, Represents a phenyl group which may be substituted with a cyano group, a nitro group, an amino group, a dimethylamino group, an acetamido group, a methanesulfonylamide group, an acetyl group or a lower alkoxycarbonyl group; or a naphthyl group. Further, R4 and R5 each independently represent a phenyl group or a lower alkyl group, and W represents an oxygen atom or a sulfur atom, respectively. [0016] R+ represents a hydrogen atom; a lower alkyl group; a benzyl group; a methoxy group; a phenyl group; an allyl group; a lower alkyl group substituted with a trifluoromethyl group or a lower alkoxy group; or a cyclopropylmethyl group. [0017] R2 each represents a hydrogen atom or a lower alkyl group, or R1 and R2 may be linked to form an alicyclic five- or six-membered ring. [0018] The lower alkyl group as R4 and R5 is preferably an alkyl group having 1 or 2 carbon atoms,
The lower alkyl group as R3 is preferably an alkyl group having 1 to 3 carbon atoms, and the lower alkyl group substituted with the furyl group or thienyl group as R3 is preferably an alkyl group having 1 to 3 carbon atoms.
-3 alkyl groups are preferred, and the alkoxy groups of the lower alkoxy group, lower alkyl group, and lower alkoxycarbonyl group substituted by the phenyl group as R3 are preferably those having 1 or 2 carbon atoms. [0019] Furthermore, as the lower alkyl group as R1, an alkyl group having 1 to 4 carbon atoms is preferable, and as the lower alkyl group substituted with a lower alkoxy group as R1,
A lower alkyl group having 1 or 2 carbon atoms substituted with an alkoxy group having 1 or 2 carbon atoms is preferred. [00201 Furthermore, the lower alkyl group as R2 is preferably an alkyl group having 1 or 2 carbon atoms. Hypohalides On the other hand, the hypohalides to be reacted with the alcohols of the above general formula [I] are of the following general formula [II]M (0-X
)...Represented by [II]. [00211 In the general formula [II], M represents an alkali metal or an alkaline earth metal. Examples of alkali metals include lithium, sodium, potassium,
Examples include cesium. [0022] Examples of alkaline earth metals include magnesium, calcium, strontium, barium, and the like. [0023] Group X represents a halogen atom, such as chlorine, bromine, and iodine. n represents 1 when M is an alkali metal, and represents 2 when M is an alkaline earth metal. Pyridines and their acid addition salts and alcohols of the above general formula [I] can be added to the alcohols of the above general formula [I].
The pyridine to be reacted with the hypohalide of [II] has the following general formula [III] [0024]
【化6】
“鴛
N ・・・ [III]で表わされる。
[0025]一般式[III]において基YおよびZは
水素原子または低級アルキル基を示す。かかるピリジン
類としては、具体的には
[0026][0025] In the general formula [III], the groups Y and Z represent a hydrogen atom or a lower alkyl group.Specifically, such pyridines include [0026]
【化7】
を例示することができる。
[0027]また、一般式[III]のピリジン類の酸
付加塩としては、たとえば、塩酸、臭化水素酸、硝酸、
硫酸、リン酸等の鉱酸類、メタンスルホン酸、ベンゼン
スルホン酸、トルエンスルホン酸、酢酸、プロピオン酸
等の有機酸類との付加塩を挙げることができ、これらの
酸付加塩類は任意の割合で一般式[III]のピリジン
類と存在していてもよい。
ケトン類
上記一般式[I]より製造されるケトン類は下記一般式
[IV]
R−CO−CHR+ R2・・・[IV]で表わされる
。
[0028]一般式[IV]において、Rは[0029
][Image Omitted] [Image Omitted] [0027] Furthermore, examples of acid addition salts of pyridines of general formula [III] include hydrochloric acid, hydrobromic acid, nitric acid,
Examples include addition salts with mineral acids such as sulfuric acid and phosphoric acid, and organic acids such as methanesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, acetic acid, and propionic acid. It may also be present with pyridines of formula [III]. Ketones Ketones produced from the above general formula [I] are represented by the following general formula [IV] R-CO-CHR+ R2...[IV]. [0028] In general formula [IV], R is [0029
]
【化8】
または
を表わす。
[00301ただしR3はハロゲン;低級アルキル基;
ベンジル基;ベンゾイル基;ピリジル基;低級アルキル
基で置換されていても良いフリル基;低級アルキル基で
置換されていても良いチエニル基;ハロゲン、低級アル
コキシ基、低級アルキル基、トリフロロメチル基、シア
ノ基、ニトロ基、アミノ基、ジメチルアミノ基、アセト
アミド基、メタンスルホニルアミド基、アセチル基また
は低級アルコキシカルボニル基で置換されていても良い
フェニル基;またはナフチル基を表わす。また、R4及
びR5はそれぞれ独立してフェニル基または低級アルキ
ル基を、Wは酸素原子またはイオウ原子をそれぞれ表わ
す。
[0031] R+ は水素原子;低級アルキル基;ベ
ンジル基;メトキシ基;フェニル基;アリル基;トリフ
ロロメチル基もしくは低級アルコキシ基で置換した低級
アルキル基;またはシクロプロピルメチル基を表わす。
[0032]R2は水素原子または低級アルキル基をそ
れぞれ表わすか、またはR1とR2が連結して脂環式五
員環もしくは六員環を形成しているものであっても良い
。
[0033]なお、R4及びR5としての低級アルキル
基としては炭素数1または2のアルキル基が好ましく、
R3としての低級アルキル基としては炭素数1〜3のア
ルキル基が好ましく、R3としてのフリル基もしくはチ
エニル基に置換される低級アルキル基としては炭素数1
〜3のアルキル基が好ましく、R3としてのフェニル基
に置換される低級アルコキシ基、低級アルキル基及び低
級アルコキシカルボニル基のアルコキシ基としては炭素
:数1または2のものが好ましい。
[0034]また、R1としての低級アルキル基として
は炭素数1〜4のアルキル基が好ましく、R1としての
低級アルコキシ基で置換した低級アルキル基としては、
炭素数1または2のアルコキシ基で置換した炭素数1ま
たは2の低級アルキル基が好ましい。
[0035]また、R2としての低級アルキル基として
は炭素数1または2のアルキル基が好ましい。
アミン類
一方、上記一般式[IV]と反応させるべきアミン類は
下記一般式[V]
NHR6R7・・・[V]
で表わされる。
[0036]一般式[V]において、基R6およびR7
は次の2つのタイプの基を示す。
[0037] 1.低級アルキル基を示し、R6とR
7とは同一であってもよいし、あるいは互いに異なる基
であってもよい。
[0038] 2.Re とR7とが互いに結合して、
窒素原子とともに5員環及至8員環の環を形成している
。この環は分岐を有していてもよい。
[0039]前記タイプ1の低級アルキル基としては、
例えばメチル基、エチル基、イソプロピル基、ブチル基
等を挙げることができる。[Chemical formula 8] represents or. [00301 However, R3 is halogen; lower alkyl group;
Benzyl group; benzoyl group; pyridyl group; furyl group optionally substituted with lower alkyl group; thienyl group optionally substituted with lower alkyl group; halogen, lower alkoxy group, lower alkyl group, trifluoromethyl group, Represents a phenyl group which may be substituted with a cyano group, a nitro group, an amino group, a dimethylamino group, an acetamido group, a methanesulfonylamide group, an acetyl group or a lower alkoxycarbonyl group; or a naphthyl group. Further, R4 and R5 each independently represent a phenyl group or a lower alkyl group, and W represents an oxygen atom or a sulfur atom, respectively. [0031] R+ represents a hydrogen atom; a lower alkyl group; a benzyl group; a methoxy group; a phenyl group; an allyl group; a lower alkyl group substituted with a trifluoromethyl group or a lower alkoxy group; or a cyclopropylmethyl group. [0032] R2 each represents a hydrogen atom or a lower alkyl group, or R1 and R2 may be linked to form an alicyclic five- or six-membered ring. [0033] The lower alkyl group as R4 and R5 is preferably an alkyl group having 1 or 2 carbon atoms,
The lower alkyl group as R3 is preferably an alkyl group having 1 to 3 carbon atoms, and the lower alkyl group substituted with the furyl group or thienyl group as R3 is preferably an alkyl group having 1 to 3 carbon atoms.
-3 alkyl groups are preferred, and the lower alkoxy group, lower alkyl group, and lower alkoxycarbonyl group substituted by the phenyl group as R3 preferably have 1 or 2 carbon atoms. [0034] Furthermore, as the lower alkyl group as R1, an alkyl group having 1 to 4 carbon atoms is preferable, and as the lower alkyl group substituted with a lower alkoxy group as R1,
A lower alkyl group having 1 or 2 carbon atoms substituted with an alkoxy group having 1 or 2 carbon atoms is preferred. [0035] Furthermore, the lower alkyl group as R2 is preferably an alkyl group having 1 or 2 carbon atoms. On the other hand, the amines to be reacted with the above general formula [IV] are represented by the following general formula [V] NHR6R7...[V]. [0036] In the general formula [V], groups R6 and R7
represents two types of groups: [0037] 1. Indicates a lower alkyl group, R6 and R
7 may be the same group or may be different groups from each other. [0038] 2. Re and R7 combine with each other,
Together with the nitrogen atom, it forms a 5- to 8-membered ring. This ring may have branches. [0039] The lower alkyl group of type 1 is:
Examples include methyl group, ethyl group, isopropyl group, and butyl group.
【0040】更に、タイプ2の5員環及至8員環として
は、
[00411Furthermore, as type 2 5- to 8-membered rings, [00411
【化9]
合成反応
本発明の製造方法においては、上記一般式[I]のアル
コール類を上記一般式[II]のハイポハライド類[I
I]と上記一般式[III]のピリジン類またはその酸
付加塩類の存在下で反応させて、上記一般式[IV]の
ケトン類を合成する。
[0042]さらに、このケトン類を上記一般式[V]
のアミン類とホルムアルデヒド水溶液の存在下で反応さ
せて上記一般式[VI]のアミノケトン類の合成を行な
う。
[0043] この合成反応は前記反応式(1)および
反応式(2)で表わされる。
[0044]前記反応式(1)中、前記一般式[IV]
のケトン類の合成に際して用いられる前記一般式[II
]のハイポハライド類は、前記一般式[I]のアルコー
ル類に対して通常モル比で0. 5及至20、好ましく
は1及至5の割合で使用される。
[0045] これら前記一般式[II]のハイポハラ
イド類は必要により水溶液として用いることができ、滴
下等の手段により反応液中に存在させることができる。
[0046]また、前記一般式[III]のピリジン類
またはその酸付加塩類は前記一般式[I]のアルコール
類に対して通常モル比で0.01及至10、好ましくは
0゜1及至5の割合で使用される。
[0047]これら前記一般式[III]のピリジン類
またはその酸付加塩類は必要により、水または酢酸、塩
酸、硫酸、リン酸等の酸性水溶液類、メタノール、エタ
ノール、イソプロパツール等のアルコール類、ジオキサ
ン等のエーテル類、クロロホルム、ジクロロメタン、■
、2ジクロロエタン、1. 1. 2−トリクロロエタ
ン等のハロゲン化炭化水素類及びアセトニトリル、ジメ
チルホルムアミド等の溶液として用い、滴下等により反
応液中に存在させることができる。
[0048]また、反応に際しては、必要により、反応
溶媒として、ヘキサン、ペンタン、シクロヘキサン等の
炭化水素類、ベンゼン、トルエン、キシレン等の芳香族
炭化水素類、メタノール、エタノール、イソプロパツー
ル等のアルコール類、テトラヒドロフラン、ジオキサン
等のエーテル類、クロロホルム、ジクロロメタン、四塩
化炭素、1,2−ジクロロエタン、1. 1. 2−)
−ジクロロエタン等のハロゲン化炭化水素類、酢酸メチ
ル、酢酸エチル、酢酸プロピル等のエステル類及び水、
アセトニトリル、ジメチルホルムアミド、ジメチルスル
ホキシド、N−メチル−2−ピロリドン等を用いること
ができる。
[0049]反応は前記一般式[I]のアルコール類と
前記一般式[II]のハイポハライド類および前記一般
式[III]のピリジン類またはその酸付加塩類とを無
溶媒下、或いは前記溶媒中で、通常は一50及至50℃
、好適には一30及至40℃の温度範囲で0.5及至4
8時間混合攪拌することによって行なわれる。
[00501反応終了後、溶媒抽出等の通常用いられる
手段によって、目的物の前記一般式[IV]のケトン類
が分離される。
[00511更に必要に応じて、再結晶、クロマトグラ
フィー等それ自体公知の精製手段が適宜採用される。
[0052]一方、前記反応式(2)中、前記一般式[
VI]のアミノケトン類の合成に際して用いられる前記
一般式[V]のアミン類は前記一般式[IV]のケトン
類に対して通常、モル比で0.5及至5、好ましくは1
及至2の割合で使用される。
[00531更に、ホルムアルデヒド水溶液は通常5及
至50%濃度、好ましくは10及至40%濃度で使用さ
れ、前記一般式[IV]のケトン類に対してモル比で通
常0.5及至5、好ましくは1及至2の割合で使用され
る。
[0054]また、反応に際しては、必要により反応溶
媒として、メタノール、エタノール、イソプロパツール
、プロパツール、ブタノール、アミルアルコール、イソ
アミルアルコール等のアルコール類を用いることができ
る。
[0055]反応は、前記一般式[IV]のケトン類を
前記一般式[V]のアミン類及びホルムアルデヒド水溶
液の存在下、無溶媒、或いは前記溶媒中で通常、−30
及至100℃、好適には一10及至60℃の温度範囲で
0.5及至24時間混合攪拌することによって行なわれ
る。
[0056]反応終了後、溶媒抽出等の通常用いられる
手段によって目的物の前記一般式[VI]のアミノケト
ン類が分離される。
[00571更に、必要に応じて、再結晶、クロマトグ
ラフィー等のそれ自体公知の精製手段が適宜採用される
。
[0058]
【発明の効果】かくして本発明によれば、中枢性筋弛緩
薬として極めて有用な前記一般式[VI]のアミノケト
ン類が工業的に有利な方法で製造される。
[0059]さらに本製造法においては、出発物質であ
る前記一般式[I]のアルコール類を製造して用いるに
あたり、前記一般式[II]のハイポハライド類を用い
て製造できる場合は一般式[I]のアルコール類を反応
溶液より単離することなく、本製造方法により中間体で
ある前記一般式[IV]のケトン類を同一反応容器にて
実施できる利点がある。
[00601以下に実施例により本発明について詳細に
説明する。
[00611[Chemical Formula 9] Synthesis Reaction In the production method of the present invention, the alcohol of the above general formula [I] is mixed with the hypohalide [I] of the above general formula [II].
I] in the presence of pyridines of the above general formula [III] or acid addition salts thereof, to synthesize ketones of the above general formula [IV]. [0042] Furthermore, this ketone is represented by the above general formula [V]
The aminoketones of the general formula [VI] are synthesized by reacting the amines with the above in the presence of an aqueous formaldehyde solution. [0043] This synthesis reaction is represented by the reaction formula (1) and reaction formula (2) above. [0044] In the reaction formula (1), the general formula [IV]
The above general formula [II
] The hypohalides of formula [I] are usually used in a molar ratio of 0. It is used in a ratio of 5 to 20, preferably 1 to 5. [0045] These hypohalides of the general formula [II] can be used as an aqueous solution if necessary, and can be made to exist in the reaction solution by means such as dropping. [0046] Furthermore, the pyridine of the general formula [III] or its acid addition salt is usually used in a molar ratio of 0.01 to 10, preferably 0.1 to 5, to the alcohol of the general formula [I]. used in percentages. [0047] These pyridines of the general formula [III] or acid addition salts thereof may be mixed with water or acidic aqueous solutions such as acetic acid, hydrochloric acid, sulfuric acid, and phosphoric acid, alcohols such as methanol, ethanol, and isopropanol, Ethers such as dioxane, chloroform, dichloromethane, ■
, 2 dichloroethane, 1. 1. It can be used as a solution of halogenated hydrocarbons such as 2-trichloroethane, acetonitrile, dimethylformamide, etc., and made to exist in the reaction solution by dropping or the like. [0048] In addition, in the reaction, if necessary, hydrocarbons such as hexane, pentane, and cyclohexane, aromatic hydrocarbons such as benzene, toluene, and xylene, and alcohols such as methanol, ethanol, and isopropanol are used as reaction solvents. ethers such as tetrahydrofuran and dioxane, chloroform, dichloromethane, carbon tetrachloride, 1,2-dichloroethane, 1. 1. 2-)
- halogenated hydrocarbons such as dichloroethane, esters such as methyl acetate, ethyl acetate, propyl acetate, and water;
Acetonitrile, dimethylformamide, dimethylsulfoxide, N-methyl-2-pyrrolidone, etc. can be used. [0049] The reaction is carried out by combining the alcohol of the general formula [I], the hypohalide of the general formula [II], and the pyridine of the general formula [III] or an acid addition salt thereof in the absence of a solvent or in the solvent. The temperature is usually between 150 and 50 degrees Celsius.
, preferably 0.5 to 4 in the temperature range of -30 to 40°C.
This is done by mixing and stirring for 8 hours. [00501] After the reaction is completed, the target ketones of general formula [IV] are separated by commonly used means such as solvent extraction. [00511 Furthermore, if necessary, purification means known per se such as recrystallization and chromatography may be appropriately employed. [0052] On the other hand, in the reaction formula (2), the general formula [
The amines of the general formula [V] used in the synthesis of the aminoketones of the general formula [IV] are usually in a molar ratio of 0.5 to 5, preferably 1 to the ketones of the general formula [IV].
It is used at a ratio of 1 to 2. [00531 Furthermore, the formaldehyde aqueous solution is usually used at a concentration of 5 to 50%, preferably 10 to 40%, and the molar ratio to the ketone of the general formula [IV] is usually 0.5 to 5, preferably 1. It is used at a ratio of 1 to 2. [0054] Further, in the reaction, alcohols such as methanol, ethanol, isopropanol, propatool, butanol, amyl alcohol, and isoamyl alcohol can be used as a reaction solvent if necessary. [0055] The reaction is carried out by converting the ketone of the general formula [IV] into -30 amines of the general formula [V] and in the presence of an aqueous formaldehyde solution without a solvent or in the solvent.
This is carried out by mixing and stirring for 0.5 to 24 hours at a temperature range of from -100°C to 100°C, preferably from -10 to 60°C. [0056] After the reaction is completed, the target aminoketones of the general formula [VI] are separated by commonly used means such as solvent extraction. [00571 Furthermore, purification means known per se, such as recrystallization and chromatography, may be employed as appropriate. [0058] According to the present invention, aminoketones of the general formula [VI], which are extremely useful as central muscle relaxants, can be produced by an industrially advantageous method. [0059] Furthermore, in this production method, when producing and using the alcohol of the general formula [I] as a starting material, if it can be produced using the hypohalide of the general formula [II], the general formula [ This production method has the advantage that the ketones of the general formula [IV], which are intermediates, can be produced in the same reaction vessel without isolating the alcohols of formula [I] from the reaction solution. [00601 The present invention will be explained in detail below using Examples. [00611
【実施例]参考例15−(1−ヒドロキシプロピル)3
−フェニルイソオキサゾール(一般式[I]の化合物)
の合成;
[0062]
【化10】
ベンズアルドキシム2. 5g (20,7mmol
)、■−ペンチンー3−オール2. Ig (25
,0mmol)をジクロロメタン12.5mlに溶解し
た。
[0063]水冷下、この溶液に12.0%ナトリウム
ハイポクロライド水溶液14.5gを滴下した。
[0064]滴下終了後、室温にて3時間反応後、ジク
ロロメタンにて有機層を抽出した。水洗後、有機層を無
水硫酸ナトリウムにて乾燥した。
[0065]減圧下、溶媒を留去し、残渣をシリカゲル
カラムクロマトグラフィー(クロロホルム溶出)にて精
製すると目的物である5−(1−ヒドロキシプロピル)
−3−フェニルイソオキサゾールが結晶として得られた
。
[0066]収量 3. 3g (収率78.7%
)融点 101〜102℃
NMR(δppm、 CDC13) 1. 0 (
3H,t、 J=8Hz)1、 6〜2. 2 (2H
,m) 3. 1 (LH,bs) 4゜9 (L
H,t、 J=6Hz) 6. 5 (LH,s)
7. 3〜7、 6 (3H,m) 7. 7
〜7. 9 (2H,m)参考例25−(1−ヒドロキ
シブチル)−3−フェニルイソオキサゾール(一般式[
I]の化合物)の合成;[0067][Example] Reference example 15-(1-hydroxypropyl)3
-Phenyl isoxazole (compound of general formula [I])
Synthesis of; [0062] embedded image Benzaldoxime 2. 5g (20.7mmol
), ■-pentyn-3-ol2. Ig (25
,0 mmol) was dissolved in 12.5 ml of dichloromethane. [0063] 14.5 g of a 12.0% aqueous sodium hypochloride solution was added dropwise to this solution under water cooling. [0064] After completion of the dropwise addition, the reaction mixture was reacted at room temperature for 3 hours, and then the organic layer was extracted with dichloromethane. After washing with water, the organic layer was dried over anhydrous sodium sulfate. [0065] The solvent is distilled off under reduced pressure, and the residue is purified by silica gel column chromatography (chloroform elution) to obtain the target product, 5-(1-hydroxypropyl).
-3-Phenyl isoxazole was obtained as crystals. [0066] Yield 3. 3g (yield 78.7%
) Melting point 101-102°C NMR (δppm, CDC13) 1. 0 (
3H, t, J=8Hz) 1, 6-2. 2 (2H
, m) 3. 1 (LH, bs) 4゜9 (L
H, t, J=6Hz) 6. 5 (LH,s)
7. 3-7, 6 (3H, m) 7. 7
~7. 9 (2H,m) Reference Example 25-(1-hydroxybutyl)-3-phenylisoxazole (general formula [
Synthesis of compound I); [0067]
【化11】
ベンズアルドキシム5. 0g (41,3mmol
)および1−ヘキシン−3−オール4. 5g (4
5,9mmol)をジクロロメタン25m1に溶解した
。
[0068]水冷下、この溶液に12.0%ナトリウム
ハイポクロライド水溶液29.0gを30分間で滴下し
た。
[0069]滴下終了後、20℃にて2時間反応を続け
た。
[00701反応終了後、ジクロロメタン抽出し、有機
層を水洗した。
[0071]無水硫酸ナトリウム乾燥後、減圧下、溶媒
を留去した。
[0072]残渣をシリカゲルカラムクロマトグラフィ
ー(クロロホルム溶出)にて精製すると目的物である5
−(1−ヒドロキシブチル)−3−フェニルイソオキサ
ゾールが油状物として得られた。
[0073]収量 6. 5g (収率72.5%
)NMR(δppm、 CDC13) 0. 7〜
1. 1 (3H,m)1、 1〜2. 1 (4
H,m) 3. 8 (LH,m) 4. 8(
LH,t、 J=7Hz) 6.4 (LH,s)
7. 2〜7゜5 (3H,m) 7. 5〜7
. 9 (2H,m)実施例15−プロピオニル−3−
フェニルイソオキサゾール(一般式[IV]の化合物)
の合成;[0074]embedded image Benzaldoxime 5. 0g (41.3mmol
) and 1-hexyn-3-ol4. 5g (4
5.9 mmol) was dissolved in 25 ml of dichloromethane. [0068] 29.0 g of a 12.0% aqueous sodium hypochloride solution was added dropwise to this solution over 30 minutes while cooling with water. [0069] After the dropwise addition was completed, the reaction was continued at 20°C for 2 hours. [00701 After the reaction was completed, dichloromethane extraction was performed, and the organic layer was washed with water. [0071] After drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. [0072] Purification of the residue by silica gel column chromatography (chloroform elution) yields the desired product 5
-(1-Hydroxybutyl)-3-phenylisoxazole was obtained as an oil. [0073] Yield 6. 5g (yield 72.5%
) NMR (δppm, CDC13) 0. 7~
1. 1 (3H, m) 1, 1-2. 1 (4
H, m) 3. 8 (LH, m) 4. 8(
LH, t, J=7Hz) 6.4 (LH, s)
7. 2-7゜5 (3H, m) 7. 5-7
.. 9 (2H,m)Example 15-propionyl-3-
Phenyl isoxazole (compound of general formula [IV])
Synthesis of; [0074]
【化12】
5−(i−ヒドロキシプロピル)−3−フェニルイソオ
キサゾール1. 0g (5,0mmol)をジクロ
ロメタン10m1に溶解した。
[0075] これにピリジン塩酸塩100mg (0
,9mmo1)を加え、さらにカルシウムハイポクロラ
イド1.4g (9,9mmol)を加えて室温下5
時間反応した。
[0076]反応終了後、不溶物を濾去し、有機層を水
洗した。
[0077]無水硫酸ナトリウムにて有機層を乾燥後、
減圧下溶媒を留去し、残渣をエタノールより再結晶する
と目的である5−プロピオニル−3−フェニルイソオキ
サゾールが結晶として得られた。
[0078]収量 0. 9g (収率91.0%
)融点 111〜112℃
NMR(δppL CDC13) 1. 3 (3
H,t、 J=8Hz)3、 1 (2H,q、 J
=8Hz) 7. 2 (3H,s) 7. 5
〜8. 0 (5H,m)
実施例2−15−ブチリル−3−フェニルイソオキサゾ
ール(一般式[IV]の化合物)の合成;[0079]embedded image 5-(i-hydroxypropyl)-3-phenylisoxazole 1. 0 g (5.0 mmol) was dissolved in 10 ml of dichloromethane. [0075] To this, 100 mg of pyridine hydrochloride (0
, 9 mmol 1), and further added 1.4 g (9.9 mmol) of calcium hypochloride,
Time reacted. [0076] After the reaction was completed, insoluble matter was filtered off, and the organic layer was washed with water. [0077] After drying the organic layer with anhydrous sodium sulfate,
The solvent was distilled off under reduced pressure, and the residue was recrystallized from ethanol to obtain the desired 5-propionyl-3-phenylisoxazole as crystals. [0078] Yield 0. 9g (Yield 91.0%
) Melting point 111-112°C NMR (δppL CDC13) 1. 3 (3
H, t, J=8Hz) 3, 1 (2H, q, J
=8Hz) 7. 2 (3H,s) 7. 5
~8. 0 (5H, m) Example 2-1 Synthesis of 5-butyryl-3-phenylisoxazole (compound of general formula [IV]); [0079]
【化13】
5−’(1−ヒドロキシブチル)−3−フェニルイソオ
キサゾール4.4g (20mmol)をジクロロメ
タン12゜5mlに溶解した。
(00801この溶液を攪拌しながら、この中に12゜
7%次亜塩素酸ナトリウム水溶液35. 2g (6
0mm。
l)を滴下した。
[0081]次に混合溶液(6N−塩酸1. 0mlに
ピリジン0. 48g (6,1mmol)を加えた溶
液)を内温を20℃に保ちながら1時間かけて滴下した
。
[0082]反応終了後、有機層を分離し5%亜硫酸水
素ナトリウム水溶液、水、IN塩酸水溶液で順次洗浄し
た。無水硫酸ナトリウムにて乾燥後、減圧下溶媒を留去
し、残渣をエタノールより再結晶すると目的とする5−
ブチリル−3−フェニルイソオキサゾールが結晶として
得られた。
(0083]収量 2. 9g (収率66.5%
)融点 89〜90℃
NMR(δppm、 CDC13) 1. 0
(3H,t、 J=7Hz)1、 5〜2. 1 (
2H,m) 2. 0 (2H,t、 J=7Hz
)7、 2 (IH,s) 7. 3〜7. 6
(3H,m) 7. 6〜8. 0 (2H,m
)
実施例2−25−ブチリル−3−フェニルイソオキサゾ
ール(一般式[IV]の化合物)の合成;[0084]embedded image 4.4 g (20 mmol) of 5-'(1-hydroxybutyl)-3-phenylisoxazole was dissolved in 12.5 ml of dichloromethane. (00801 While stirring this solution, add 35.2 g of 12°7% sodium hypochlorite aqueous solution (6
0mm. l) was added dropwise. [0081] Next, a mixed solution (a solution of 0.48 g (6.1 mmol) of pyridine added to 1.0 ml of 6N hydrochloric acid) was added dropwise over 1 hour while maintaining the internal temperature at 20°C. [0082] After the reaction was completed, the organic layer was separated and washed successively with a 5% aqueous sodium bisulfite solution, water, and an IN aqueous hydrochloric acid solution. After drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the residue was recrystallized from ethanol to obtain the desired 5-
Butyryl-3-phenylisoxazole was obtained as crystals. (0083) Yield 2.9g (Yield 66.5%
) Melting point 89-90°C NMR (δppm, CDC13) 1. 0
(3H, t, J=7Hz) 1, 5-2. 1 (
2H, m) 2. 0 (2H, t, J=7Hz
)7, 2 (IH,s) 7. 3-7. 6
(3H, m) 7. 6-8. 0 (2H, m
) Example 2-2 Synthesis of 5-butyryl-3-phenylisoxazole (compound of general formula [IV]); [0084]
【化14】
ベンズアルドキシム2. 5g (20,6mmol
)および1−ヘキシン−3−オール2.3g (22
,9mmol)をジクロロメタン12.5mlに溶解し
た。
[0085]水冷下、この溶液に12%Na0Cl水溶
液15.6g反応温度を5℃に保ちながら滴下した。
[0086]その後室温にて3時間攪拌を続け5−(1
−ヒドロキシブチル)−3−フェニルイソオキサゾール
の反応溶液を得た。
[0087] この溶液に12%Na0C1水溶液39
.0gを加え、更にピリジン塩酸塩0. 7g (6
,1mmol)の水3ml溶液を反応温度を15〜20
℃に保ちながら滴下した。
[0088]さらに同温度にて1時間反応を続けた。
[0089]反応終了後、有機層を分離し5%亜硫酸水
素ナトリウム水溶液、水、IN塩酸水溶液で順次洗浄し
た。無水硫酸ナトリウムにて乾燥後、減圧下溶媒を留去
し、残渣をエタノールより再結晶すると目的である5−
ブチリル−3−フェニルイソオキサゾールが結晶として
得られた。embedded image Benzaldoxime 2. 5g (20.6mmol
) and 2.3 g of 1-hexyn-3-ol (22
, 9 mmol) was dissolved in 12.5 ml of dichloromethane. [0085] Under water cooling, 15.6 g of a 12% Na0Cl aqueous solution was added dropwise to this solution while maintaining the reaction temperature at 5°C. [0086] After that, stirring was continued for 3 hours at room temperature, and 5-(1
A reaction solution of -hydroxybutyl)-3-phenylisoxazole was obtained. [0087] Add 12% Na0C1 aqueous solution 39 to this solution.
.. Add 0.0 g of pyridine hydrochloride, and add 0.0 g of pyridine hydrochloride. 7g (6
, 1 mmol) in 3 ml of water at a reaction temperature of 15-20
It was added dropwise while keeping the temperature at °C. [0088] The reaction was further continued at the same temperature for 1 hour. [0089] After the reaction was completed, the organic layer was separated and washed successively with 5% aqueous sodium bisulfite solution, water, and IN aqueous hydrochloric acid solution. After drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the residue was recrystallized from ethanol to obtain the desired 5-
Butyryl-3-phenylisoxazole was obtained as crystals.
【0090】収量 2. 8g (収率63.7%
)融点とNMRは実施例2−1で合成したものに一致し
た。
実施例3〜5
実施例2−1においてアルコール類として表1に示した
ものを用いる以外は実施例2−1と同様な反応を行なう
ことによって表1記載の目的物質である一般式[IV]
の化合物であるケトン類が得られた。
[0091]Yield 2. 8g (yield 63.7%
) The melting point and NMR were consistent with that synthesized in Example 2-1. Examples 3 to 5 The same reaction as in Example 2-1 was carried out except that the alcohols shown in Table 1 were used in Example 2-1 to obtain the target substance of general formula [IV] shown in Table 1.
A compound of ketones was obtained. [0091]
【表1】
表
実施例65−(2−ピペリジノメチルプロピオニル)−
3−フェニルイソオキサゾール(一般式[VI]の化合
物)の合成;
[0092][Table 1] Table Example 65-(2-piperidinomethylpropionyl)-
Synthesis of 3-phenylisoxazole (compound of general formula [VI]); [0092]
【化15】
5−゛プロピオニルー3−フェニルイソオキサゾール2
゜Og (10,0mmol)およびピペリジン1.
7g (20、0mmol)をエチルアルコール1
0m1に加え、水冷下37%ホルムアルデヒド水溶液1
. 63m1 (20,0mmo1)を滴下した。さら
に室温で2時間攪拌した後、減圧下溶媒を留去した。
[0093]得られた残渣をエチルエーテルに溶解し、
有機層を水洗後、無水硫酸ナトリウムで乾燥した。
[0094]減圧下溶媒を留去すると目的である5(2
−ピペリジノメチルプロピオニル)−3−フェニルイソ
オキサゾールが結晶として得られた。
[0095]収量 2. 3g (収率78%)融
点 114〜116℃
NMR(δppm、 CDC13) 1. 3 (
3H,d、 J=6Hz)1、 5〜1. 8 (6H
,m) 2. 3〜3. 0 (6H,m)3、 5
〜4. 0 (LH,m) 7. 2 (LH,s)
7. 5〜7. 7 (3H,m) 7. 7〜8
. 0 (2H,m)実施例75−(2−ピロリジノメ
チルブチリル)−3−フェニルイソオキサゾール(一般
式[VI]の化合物)の合成;
[0096]embedded image 5-propionyl-3-phenylisoxazole 2
°Og (10,0 mmol) and piperidine 1.
7g (20.0mmol) in 1 part ethyl alcohol
0 ml plus 1 ml of 37% formaldehyde aqueous solution under water cooling.
.. 63 ml (20.0 mmol) was added dropwise. After further stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure. [0093] Dissolve the obtained residue in ethyl ether,
The organic layer was washed with water and then dried over anhydrous sodium sulfate. [0094] When the solvent is distilled off under reduced pressure, the desired 5(2
-piperidinomethylpropionyl)-3-phenylisoxazole was obtained as crystals. [0095] Yield 2. 3g (yield 78%) Melting point 114-116°C NMR (δppm, CDC13) 1. 3 (
3H, d, J=6Hz) 1, 5-1. 8 (6H
, m) 2. 3-3. 0 (6H, m)3, 5
~4. 0 (LH, m) 7. 2 (LH,s)
7. 5-7. 7 (3H, m) 7. 7-8
.. 0 (2H,m) Example 7 Synthesis of 5-(2-pyrrolidinomethylbutyryl)-3-phenylisoxazole (compound of general formula [VI]); [0096]
【化16】
5−’(2−ピロリジノメチルブチリル)−3−フェニ
ルイソオキサゾール200g (0,93モル)およ
びピロリジン110m1 (1,32モル)をエチルア
ルコール400m1に加え、水冷下、37%ホルムアル
デヒド水溶液120m1 (1,48モル)を30分間
かけて滴下した。
[0097]さらに室温で1.5時間攪拌した後、減圧
不反応液を濃縮乾固した。
[0098]得られた残渣をエチルエーテル1リツトル
に溶解し、水洗の後、無水硫酸マグネシウムを用いて有
機層を乾燥して溶媒を留去し、5−(2−ピロリジノメ
チルブチリル)−3−フェニルイソオキサゾールを無色
結晶として得られた。
[0099]収量 264g(収率95.2%)融点
68〜69℃
NMR(δppm、 CDC13) 0. 9 (
3H,t、 J−7Hz)1、 3〜2. 0 (6H
,m) 7. 2 (IH,s) 7. 2〜
7. 6 (3H,m) 7. 6〜8. 0 (2
H,m)実施例85−(2−ピペリジノメチルブチリル
)−3−フェニルイソオキサゾール(一般式[VI]の
化合物)の合成;
[01001[Chemical formula 16] 200 g (0.93 mol) of 5-'(2-pyrrolidinomethylbutyryl)-3-phenylisoxazole and 110 ml (1.32 mol) of pyrrolidine were added to 400 ml of ethyl alcohol, and a mixture of 37% 120 ml (1.48 mol) of formaldehyde aqueous solution was added dropwise over 30 minutes. [0097] After further stirring at room temperature for 1.5 hours, the unreacted liquid was concentrated to dryness under reduced pressure. [0098] The obtained residue was dissolved in 1 liter of ethyl ether, washed with water, the organic layer was dried using anhydrous magnesium sulfate, the solvent was distilled off, and 5-(2-pyrrolidinomethylbutyryl)- 3-phenylisoxazole was obtained as colorless crystals. [0099] Yield 264g (yield 95.2%) Melting point 68-69°C NMR (δppm, CDC13) 0. 9 (
3H, t, J-7Hz) 1, 3-2. 0 (6H
, m) 7. 2 (IH,s) 7. 2~
7. 6 (3H, m) 7. 6-8. 0 (2
H, m) Example 8 Synthesis of 5-(2-piperidinomethylbutyryl)-3-phenylisoxazole (compound of general formula [VI]); [01001
【化17]
5−ブチリル−3−フェニルイソオキサゾール160g
(0,74モル)およびピペリジン103m1をエチル
アルコール320m1に加え、水冷下、37%ホルムア
ルデヒド水溶液96m1 (1,18モル)を30分で
滴下した。
[0101]室温で1.5時間攪拌した後、溶媒を留去
した。
[0102]得られた残渣をエチルエーテル800m1
に溶解し、水洗の後、無水硫酸マグネシウムを用いて乾
燥した。
[0103]溶媒を留去して、目的とする5−(2−ピ
ペリジノメチルブチリル)−3−フェニルイソオキサゾ
ールを無色結晶として得た。
[0104]収量 223g (収率96.0%)融
点 83〜84℃
NMR(δppm、 CDC13) 0. 8〜1
. 1 (3H,m)1、 2〜2. 0 (8H,
m) 3.4〜3. 8 (LH,m)7、 1
(IH,S) 7. 3〜7. 6 (3H,m)
7. 6〜8. 0 (2H,m)
実施例9〜16
実施例9〜12については、実施例6におけるピペリジ
ンの代りに表2に示す−NR6R7基導入用の各アミン
HNR6R7(NR6R7は表2に示すものに対応する
)を用いる以外は実施例6と同様にして表2に示す各ア
ミノケトンを得た。
[0105]実施例13については、実施例7における
ピロリジンの代りに2−メチルピロリジンを用いる以外
は実施例7と同様にして表2に示すアミノケトンを得た
。
[0106]実施例14〜16については実施例7にお
ける5−ブチリル−3−フェニルイソオキサゾールの代
りにそれぞれ実施例3〜4で合成したケトン類を用いる
以外は実施例7と同様にして表2に示す各アミノケトン
を得た。
[0107]得られた各アミノケトン(一般式[VI]
の化合物)の分析結果を表2に示す。
[0108]
【表2】
表
2
[0109][Chemical formula 17] 160 g of 5-butyryl-3-phenylisoxazole
(0.74 mol) and 103 ml of piperidine were added to 320 ml of ethyl alcohol, and 96 ml (1.18 mol) of a 37% formaldehyde aqueous solution was added dropwise over 30 minutes under water cooling. [0101] After stirring at room temperature for 1.5 hours, the solvent was distilled off. [0102] The obtained residue was dissolved in 800 ml of ethyl ether.
After washing with water, it was dried using anhydrous magnesium sulfate. [0103] The solvent was distilled off to obtain the desired 5-(2-piperidinomethylbutyryl)-3-phenylisoxazole as colorless crystals. [0104] Yield 223g (yield 96.0%) Melting point 83-84°C NMR (δppm, CDC13) 0. 8-1
.. 1 (3H, m) 1, 2-2. 0 (8H,
m) 3.4-3. 8 (LH, m)7, 1
(IH, S) 7. 3-7. 6 (3H, m)
7. 6-8. 0 (2H, m) Examples 9 to 16 For Examples 9 to 12, each amine HNR6R7 for introducing the -NR6R7 group shown in Table 2 was used instead of piperidine in Example 6 (NR6R7 corresponds to that shown in Table 2). The aminoketones shown in Table 2 were obtained in the same manner as in Example 6, except that the following aminoketones were used. [0105] Regarding Example 13, the aminoketone shown in Table 2 was obtained in the same manner as in Example 7 except that 2-methylpyrrolidine was used instead of pyrrolidine in Example 7. [0106] For Examples 14 to 16, Table 2 was carried out in the same manner as in Example 7 except that the ketones synthesized in Examples 3 to 4 were used instead of 5-butyryl-3-phenylisoxazole in Example 7. Each aminoketone shown in was obtained. [0107] Each of the obtained aminoketones (general formula [VI]
Table 2 shows the analysis results of the compound (compound). [0108] [Table 2] Table 2 [0109]
【表3】 表 2(続き)[Table 3] table 2 (continued)
Claims (1)
ジル基;ベンゾイル基;ピリジル基;1以上の低級アル
キル基で置換されていても良いフリル基;1以上の低級
アルキル基で置換されていても良いチエニル基;1以上
のハロゲン原子、1以上の低級アルコキシ基、低級アル
キル基、トリフロロメチル基、シアノ基、ニトロ基、ア
ミノ基、ジメチルアミノ基、アセトアミド基、メタンス
ルホニルアミド基、アセチル基または低級アルコキシカ
ルボニル基で置換されていても良いフェニル基、または
ナフチル基を;R4及びR5はそれぞれ独立してフェニ
ル基または低級アルキル基を、Wは酸素原子またはイオ
ウ原子をそれぞれ表わす)、R1は水素原子;低級アル
キル基;ベンジル基;メトキシ基;フェニル基;アリル
基;トリフロロメチル基もしくは低級アルコキシ基で置
換した低級アルキル基;またはシクロプロピルメチル基
を、R2は水素原子または低級アルキル基をそれぞれ表
わすか、またはR1とR2が連結して脂環式五員環もし
くは六員環を形成しているものであっても良い。]で表
わされるアルコール類を下記一般式[II]M (0−
X) ・・・[II][式中
、Mはアルカリ金属類またはアルカリ土類金属類、Xは
ハロゲン原子を示す。nは、Mがアルカリ金属類のとき
は1、Mがアルカリ土類金属類のときは2を示す。]で
表わされるハイポハライド類および下記一般式[] 【2】 [ [式中、YおよびZは独立に水素原子または低級アルキ
ル基を示す。]で表わされるピリジン類またはその酸付
加塩類の存在下反応させることを特徴とする下記一般式
[] %式%[] (R,R1およびR2は前記に同じ)で表わされるケト
ン類の製造方法。 【請求項2] Rが5 (3R3イソオキサゾール
)基である請求項1の方法。 【請求項3】R3がフェニル基である請求項2の方法。 【請求項4】R1が水素原子であり、R2が低級アルキ
ル基である請求項3の方法。 【請求項5】 一般式[II]のハイポハライド類が次
亜塩素酸ナトリウムである請求項1の方法。 【請求項6】 一般式[III]のピリジン類またはそ
の酸付加塩がピリジン又はピリジン塩酸塩である請求項
1の方法。 【請求項7】 一般式[II]のハイポハライド類は一
般式[I]のアルコール類に対しモル比で1〜5である
請求項1の方法。 【請求項8】 一般式[III]のピリジン類またはそ
の酸付加塩は一般式[I]のアルコール類に対してモル
比で0.1〜5である請求項1の方法。 【請求項9】 下記一般式[V] NHR6R7・・・[V] [式中、R6およびR7は低級アルキル基を示し、これ
らは同一であってもあるいは互いに異なっていてもよく
、また互いに結合して窒素原子とともに5員環及至8員
環の環を形成していてもよく、更に鎖環は1以上の分岐
を有していてもよい。]で表わされるアミン類をホルム
アルデヒド水溶液の存在下で一般式[IV]のケトン類
と反応させることによる下記一般式[VI]RCo
CRI R2CH2NR6R7・・・[VI](R,R
1、R2、R6、R7は前記に同じ)で表わされるアミ
ノケトン類の製造方法。 【請求項10】 Rが5 (3Rsイソオキサゾール
)基である請求項9の方法。 【請求項11] R3がフェニル基である請求項10
の方法。 【請求項12] R+ が水素原子であり、R2が低
級アルキル基である請求項11の方法。 【請求項13】 一般式[V]のアミノ類は一般式[
I■]のケトン類に対してモル比で1〜2である請求項
9の方法。 【請求項14】 ホルムアルデヒドは一般式[IV]
のケトン類に対してモル比で1〜2である請求項9の方
法。 【請求項15】 一般式[IV]のケトン類が請求項
1の方法で得られたものである請求項9の方法。 【請求項16】 5−ブチリル−3−フェニルイソオ
キサゾール。[Scope of Claims] [Claim 1] The following general formula [I] RCHOHCHRI R2 ... [I] [In the formula, R represents [Formula 1] and R3 is a halogen atom; a lower alkyl group; a benzyl group; benzoyl group; pyridyl group; furyl group optionally substituted with one or more lower alkyl groups; thienyl group optionally substituted with one or more lower alkyl groups; one or more halogen atoms, one or more lower alkoxy groups , a lower alkyl group, a trifluoromethyl group, a cyano group, a nitro group, an amino group, a dimethylamino group, an acetamide group, a methanesulfonylamide group, a phenyl group optionally substituted with an acetyl group or a lower alkoxycarbonyl group, or naphthyl. R4 and R5 each independently represent a phenyl group or a lower alkyl group, W represents an oxygen atom or a sulfur atom, respectively), R1 is a hydrogen atom; a lower alkyl group; a benzyl group; a methoxy group; a phenyl group; an allyl group; group; lower alkyl group substituted with trifluoromethyl group or lower alkoxy group; It may form a ring or a six-membered ring. ] Alcohols represented by the following general formula [II] M (0-
X) ... [II] [Wherein, M represents an alkali metal or an alkaline earth metal, and X represents a halogen atom. n represents 1 when M is an alkali metal, and represents 2 when M is an alkaline earth metal. ] and the following general formula [ ] [2] [ [wherein Y and Z independently represent a hydrogen atom or a lower alkyl group. ] A method for producing ketones represented by the following general formula [] % formula % [] (R, R1 and R2 are the same as above), characterized in that the reaction is carried out in the presence of pyridines represented by pyridine or acid addition salts thereof . [Claim 2] The method of Claim 1, wherein R is a 5 (3R3 isoxazole) group. 3. The method according to claim 2, wherein R3 is a phenyl group. 4. The method according to claim 3, wherein R1 is a hydrogen atom and R2 is a lower alkyl group. 5. The method according to claim 1, wherein the hypohalide of general formula [II] is sodium hypochlorite. 6. The method according to claim 1, wherein the pyridine of general formula [III] or its acid addition salt is pyridine or pyridine hydrochloride. 7. The method according to claim 1, wherein the molar ratio of the hypohalide of general formula [II] to the alcohol of general formula [I] is 1 to 5. 8. The method according to claim 1, wherein the pyridine of general formula [III] or its acid addition salt is in a molar ratio of 0.1 to 5 with respect to the alcohol of general formula [I]. [Claim 9] The following general formula [V] may form a 5- to 8-membered ring together with the nitrogen atom, and the ring chain may further have one or more branches. ] The following general formula [VI] RCo is obtained by reacting amines represented by the following with ketones of general formula [IV] in the presence of an aqueous formaldehyde solution.
CRI R2CH2NR6R7...[VI](R,R
1, R2, R6, R7 are the same as above). 10. The method of claim 9, wherein R is a 5 (3Rs isoxazole) group. [Claim 11] Claim 10 wherein R3 is a phenyl group
the method of. [Claim 12] The method according to Clause 11, wherein R+ is a hydrogen atom and R2 is a lower alkyl group. 13. Aminos of general formula [V] are represented by general formula [
The method according to claim 9, wherein the molar ratio is 1 to 2 with respect to the ketone of [I]]. [Claim 14] Formaldehyde has the general formula [IV]
10. The method according to claim 9, wherein the molar ratio to the ketones is 1 to 2. 15. The method according to claim 9, wherein the ketone of general formula [IV] is obtained by the method according to claim 1. 16. 5-Butyryl-3-phenylisoxazole.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3036527A JP2675924B2 (en) | 1990-02-08 | 1991-02-07 | Method for producing aminoketones |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2-27119 | 1990-02-08 | ||
JP2711990 | 1990-02-08 | ||
JP3036527A JP2675924B2 (en) | 1990-02-08 | 1991-02-07 | Method for producing aminoketones |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04210974A true JPH04210974A (en) | 1992-08-03 |
JP2675924B2 JP2675924B2 (en) | 1997-11-12 |
Family
ID=26365008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3036527A Expired - Lifetime JP2675924B2 (en) | 1990-02-08 | 1991-02-07 | Method for producing aminoketones |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2675924B2 (en) |
-
1991
- 1991-02-07 JP JP3036527A patent/JP2675924B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
J MED CHEM=1967 * |
Also Published As
Publication number | Publication date |
---|---|
JP2675924B2 (en) | 1997-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106905314A (en) | Method for preparing 5 fluorine 1H pyrazolo-pyridines of substitution | |
KR20190013553A (en) | Improved process for preparing aminopyrimidine derivatives | |
JPH02262558A (en) | New method for producing phenyl-1-diethylaminocarbonyl- 1-phthalimidomethyl-2-cyclopropane z | |
JP2707936B2 (en) | β-oxo-β-benzenepropanethioamide derivative | |
TWI322806B (en) | Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives | |
Zhou et al. | Samarium (II) iodide induced reductive coupling of nitriles with nitro compounds | |
TWI284127B (en) | Cyclization process for substituted benzothiazole derivatives | |
AU2001287699B2 (en) | Continuous process for the preparation of pesticidal chlorothiazoles | |
JPH04210974A (en) | Production of aminoketones | |
KR20190013554A (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
JP5327794B2 (en) | Method for producing 1,2-benzisothiazolin-3-one compound | |
TWI292397B (en) | Process for the manufacture of nitroguanidine pesticides | |
JP5009736B2 (en) | Mannich reaction using cyclic amino ether | |
US5194606A (en) | Preparation process of aminoketones | |
KR20210126614A (en) | Synthesis of 3-bromo-5-(2-ethylimidazo[1,2-a]pyridine-3-carbonyl)-2-hydroxybenzonitrile | |
US6051707A (en) | Linear process for the preparation of a morpholine compound | |
JP3882547B2 (en) | Method for producing 4-phthalonitrile derivative | |
AU747543B2 (en) | Process for converting propargylic amine-N-oxides to enaminones | |
US5055585A (en) | Preparation process of aminoketones | |
US20170158637A1 (en) | Synthetic Processes of Carprofen | |
KR100856133B1 (en) | Improved process for preparing atorvastatin | |
CN113087655B (en) | Levobupivacaine intermediate compound | |
JP3387723B2 (en) | Method for producing 2-nitroiminohexahydro-1,3,5-triazines | |
JPWO2002076958A1 (en) | Method for producing 5-substituted oxazole compound and 5-substituted imidazole compound | |
JPS5914036B2 (en) | New method for producing rifamycin SV derivatives |